Katya Zielbauer’s Post

View profile for Katya Zielbauer, graphic

Marketing Communication Manager Biologics/Viral Vector CDMO, Life Science Services, Merck KGaA, Darmstadt, Germany

Technology Transfer Considerations in Antibody Manufacturing It's inevitable. At one point, you will need to transfer a process either to another team for scale up or another CDMO. How do you best plan for your Tech Transfer? Read our short article or contact our MSAT team today. #Mammalian, #Mammalian biologics, #Antibody, #CDMO

Technology Transfer Considerations

Technology Transfer Considerations

bioprocessonline.com

To view or add a comment, sign in

Explore topics